3 things ASX investors should watch this week

The coming days are huge for your stock portfolio. Keep an eye on these developments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As reporting season continues in earnest, if you are invested in ASX shares you need to pay attention.

Fortunately for The Motley Fool readers, eToro market analyst Josh Gilbert has pointed out the three biggest events to monitor this week:

Three business people stand on platforms in the desert and look out through telescopes.

Image source: Getty Images

1. Australia unemployment

The financial markets, the Reserve Bank of Australia (RBA), and the general public will all be watching for the latest unemployment figures on Thursday.

Gilbert pointed out that December's rise to 3.9% exceeded expectations.

"December's uptick was perceived as a sign that the labour market could be loosening up, with job advertisement figures dipping and population growth remaining robust, suggesting that we might see a further rise in unemployment this week."

Similar to the rate hikes over 2022 and 2023, Gilbert reckons the RBA will again fall behind compared to its peers.

"It's likely to be one of the last major central banks to introduce rate cuts this year."

2. CSL half-year results

Biotech giant CSL Ltd (ASX: CSL) has enjoyed a 32% rise in its share price since late October.

But it recently saw a setback that could have longer term implications.

"The company's share price faced a decline [last week] following news of a UK investigation into alleged anti-competitive behaviour from CSL Vifor. 

"If found guilty, CSL faces potential fines and reputational damage, which may impact the company's FY24 results."

The last reporting season was positive for the ASX healthcare company.

"Shareholders were pleased with the healthcare giant's FY23 results, where revenue growth went up 31% year-over-year to US$13.31 billion, and the company's FY24 guidance continued to hold firm."

On Tuesday morning, the market will be watching carefully how CSL is progressing in its underlying profit guidance of US$2.9 billion to US$3 billion for FY24.

"[Investors] are keen to ascertain whether CSL has sustained its course toward recovery following the turbulence its share price experienced in 2023."

3. Telstra half-year results

Another portfolio staple, Telstra Group Ltd (ASX: TLS) is reporting on Thursday.

According to Gilbert, the telco stock has been disappointing in recent times.

"It's been a lacklustre couple of years for Telstra, with shares falling by around 2% in that time, despite a 14% jump in profitability last year.

"This week's half-year results will be a key insight as to how cost-cutting has aided the businesses bottom line."

Gilbert is optimistic about the coming results, though.

"Telstra's profits look set to continue growing. 

"In August, the business forecasted an EBITDA of $8.2 billion to $8.4 billion in FY24, well ahead of FY23's $7.86 billion."

Motley Fool contributor Tony Yoo has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »